Zobrazeno 1 - 3
of 3
pro vyhledávání: '"NEL study Group"'
Publikováno v:
Journal of Cancer Research & Therapy, Vol 5, Iss 7, Pp 45-49 (2017)
Background: Skin rash during treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI) has been reported to be predictive for response and survival in patients with advanced non-small cell lung cancer (NSCLC). The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466819e5d4d2c4f34a23198bd4894234
https://doi.org/10.14312/2052-4994.2017-9
https://doi.org/10.14312/2052-4994.2017-9
Autor:
Lankheet, Nienke A G, Schaake, Eva E, Burgers, Sjaak A, van Pel, Renée, Beijnen, Jos H, Huitema, Alwin D R, Klomp, Houke, NEL study group
INTRODUCTION: Tumors might not optimally respond to systemic therapy if minimal effective levels are not reached within the tumor. Erlotinib has mainly been studied in the adjuvant or palliative setting and, therefore, little is known about erlotinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::d3be4cae9f6c19d2abbe7961c01a7909
https://dspace.library.uu.nl/handle/1874/308233
https://dspace.library.uu.nl/handle/1874/308233
Autor:
Lankheet, Nienke A G, Schaake, Eva E, Burgers, Sjaak A, van Pel, Renée, Beijnen, Jos H, Huitema, Alwin D R, Klomp, Houke, NEL study group, NEL Study Group
Publikováno v:
Clinical Lung Cancer; Jul2015, Vol. 16 Issue 4, p320-324, 5p